Compagni A - Search Results

1

Response to COVID-19: was Italy (un)prepared?

Bosa I, Castelli A, Castelli M, Ciani O, Compagni A, Galizzi MM, Garofano M, Ghislandi S, Giannoni M, Marini G, Vainieri M. Bosa I, et al. Among authors: compagni a. Health Econ Policy Law. 2022 Jan;17(1):1-13. doi: 10.1017/S1744133121000141. Epub 2021 Mar 5. Health Econ Policy Law. 2022. PMID: 33663622 Free PMC article.

2

Corona-regionalism? Differences in regional responses to COVID-19 in Italy.

Bosa I, Castelli A, Castelli M, Ciani O, Compagni A, Galizzi MM, Garofano M, Ghislandi S, Giannoni M, Marini G, Vainieri M. Bosa I, et al. Among authors: compagni a. Health Policy. 2021 Sep;125(9):1179-1187. doi: 10.1016/j.healthpol.2021.07.012. Epub 2021 Jul 31. Health Policy. 2021. PMID: 34366171 Free PMC article. Review.

3

Pharmaceutical companies and Italian Regional Governments: managing relationships in an increasing institutional complexity.

Compagni A, Cavalli L, Jommi C. Compagni A, et al. Health Policy. 2008 Sep;87(3):333-41. doi: 10.1016/j.healthpol.2008.02.010. Epub 2008 Apr 1. Health Policy. 2008. PMID: 18384907

4

Sustaining universal health coverage: the interaction of social, political, and economic sustainability.

Borgonovi E, Compagni A. Borgonovi E, et al. Among authors: compagni a. Value Health. 2013 Jan-Feb;16(1 Suppl):S34-8. doi: 10.1016/j.jval.2012.10.006. Epub 2012 Nov 14. Value Health. 2013. PMID: 23317642 Free article.

5

Explaining the unexpected success of the smoking ban in Italy: political strategy and transition to practice, 2000–2005.

Mele V, Compagni A. Mele V, et al. Among authors: compagni a. Public Adm. 2010;88(3):819-35. doi: 10.1111/j.1467-9299.2010.01840.x. Public Adm. 2010. PMID: 20925154

6

The interplay between policy guidelines and local dynamics in shaping the scope of networks: the experience of the Italian Departments of Mental Health.

Compagni A, Gerzeli S, Bergamaschi M. Compagni A, et al. Health Serv Manage Res. 2011 Feb;24(1):45-54. doi: 10.1258/hsmr.2010.010013. Health Serv Manage Res. 2011. PMID: 21285365

7

Orphan drug legislation: lessons for neglected tropical diseases.

Villa S, Compagni A, Reich MR. Villa S, et al. Among authors: compagni a. Int J Health Plann Manage. 2009 Jan-Mar;24(1):27-42. doi: 10.1002/hpm.930. Int J Health Plann Manage. 2009. PMID: 18435430

8

Multiprofessional Primary Care Units: What Affects the Clinical Performance of Italian General Practitioners?

Armeni P, Compagni A, Longo F. Armeni P, et al. Among authors: compagni a. Med Care Res Rev. 2014 Aug;71(4):315-36. doi: 10.1177/1077558714536618. Med Care Res Rev. 2014. PMID: 24993251

9

Avoiding adverse drug reactions by pharmacogenetic testing: a systematic review of the economic evidence in the case of TPMT and AZA-induced side effects.

Compagni A, Bartoli S, Buehrlen B, Fattore G, Ibarreta D, de Mesa EG. Compagni A, et al. Int J Technol Assess Health Care. 2008 Summer;24(3):294-302. doi: 10.1017/S0266462308080392. Int J Technol Assess Health Care. 2008. PMID: 18601797 Review.

10

When peers count: The effects on integrated type II diabetes care of communication within general practitioner-only subgroups in interprofessional primary care teams.

Compagni A, Armeni P, Tasselli S. Compagni A, et al. Health Care Manage Rev. 2019 Jan/Mar;44(1):67-78. doi: 10.1097/HMR.0000000000000158. Health Care Manage Rev. 2019. PMID: 28306609

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters